CD44+/CD24- phenotype contributes to malignant relapse following surgical resection and chemotherapy in patients with invasive ductal carcinoma

CD44+/CD24- phenotype contributes to malignant relapse following surgical resection and chemotherapy in patients with invasive ductal carcinoma

Bibliographic Details
Main Authors: Lin, Yan, Zhong, Ying, Guan, Heng, Zhang, Xiaohui, Sun, Qiang
Format: Online
Language:English
Published: BioMed Central 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432011/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432011/

Similar Items